Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)
N/A
The study seeks to provide evidence of the effectiveness and obtain patient...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-06
Trial ID
NCT02582658
Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation
N/A
This prospective, multi-center, observational study is designed to assess t...
Status
Completed
Location
South-Ural State Med. Academy
Start Date
2017-03-20
Trial ID
NCT03053180
MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV
PHASE4
This is a 1:1 randomized double-blind Placebo-controlled moncenter Phase IV...
ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection
PHASE3
This is a study to evaluate ABT 450/r/ABT-267 and ABT-333 in treatment-naïv...